519 filings
Page 6 of 26
8-K
sy1sp
15 May 19
Submission of Matters to a Vote of Security Holders
4:10pm
424B5
3twzqxt hh
7 May 19
Prospectus supplement for primary offering
8:31am
8-K
7y9aru
7 May 19
MannKind Corporation Reports 2019 First Quarter Financial Results
8:00am
EFFECT
56kun rrqx7iz
8 Apr 19
Notice of effectiveness
12:15am
UPLOAD
fkhn1po4
4 Apr 19
Letter from SEC
12:00am
CORRESP
6dnenqu7
3 Apr 19
Correspondence with SEC
12:00am
DEFA14A
4svb 8pd3won8go42yw
28 Mar 19
Additional proxy soliciting materials
4:13pm
8-K
6mh3ug bkg
26 Feb 19
MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call
8:05am
8-K
vb0knmd5 xh
21 Dec 18
MannKind Announces Commencement of Public Offering
12:00am
424B5
58x7pjd3j9zoa4o
21 Dec 18
Prospectus supplement for primary offering
12:00am
424B5
i31lwdjc48
19 Dec 18
Prospectus supplement for primary offering
4:10pm
8-K
f67dp crabqglknslzom
3 Dec 18
MannKind Appoints Christine Mundkur to its Board of Directors
4:05pm
CT ORDER
ocmkg1ngcyy06wy7oudd
30 Nov 18
Confidential treatment order
11:12am
8-K
n2g95zd
1 Nov 18
MannKind Corporation Reports 2018 Third Quarter Financial Results
8:05am
8-K
yryom3z1mh9pe b22
16 Oct 18
United Therapeutics and Mannkind Announce Closing
4:58pm